Atherosclerosis is the leading cause of cardiovascular disease (CVD). Traditional risk factors can be used to identify individuals at high risk for developing CVD and are generally associated with the extent of atherosclerosis; however, substantial numbers of individuals at low or intermediate risk still develop atherosclerosis.A case-control study was performed using microarray gene expression profiling of peripheral blood from 119 healthy women in the Multi-Ethnic Study of Atherosclerosis cohort aged 50 or above. All participants had low (<10%) to intermediate (10% to 20%) predicted Framingham risk; cases (N = 48) had coronary artery calcium (CAC) score >100 and carotid intima-media thickness (IMT) >1.0 mm, whereas controls (N = 71) had C...
Low-density lipoprotein cholesterol lowering, most notably via statin therapy, has successfully redu...
Low-density lipoprotein cholesterol lowering, most notably via statin therapy, has successfully redu...
BACKGROUND:Platelets are key components in atherogenesis and determine the course of its clinical se...
Atherosclerosis is the leading cause of cardiovascular disease (CVD). Traditional risk factors can b...
BACKGROUND: Inflammation and matrix degradation are the hallmarks of high-risk atherosclerosis that ...
Atherosclerosis is the underlying cause of coronary artery disease and cerebrovascular disease. Risk...
Objective: Atherosclerosis is associated with increased levels of plasma cytokines and expression of...
Innate immunity is the first line of defence against invading micro-organisms. The family of Toll-li...
Inflammation drives atherosclerosis. Toll-like receptor-2 and -4 are so far the strongest candidates...
Background - The ability to mount a prominent inflammatory response to bacterial pathogens confers a...
Background—Transcriptional profiles are available for a variety of cardiovascular-related diseases. ...
Background: Adaptive immunity has been implicated in atherosclerosis in animal models and small clin...
Atherosclerosis is a multi-factorial inflammatory disease and is the primary initiator of cerebrovas...
Atherosclerosis is a multi-factorial inflammatory disease and is the primary initiator of coronary a...
<p>Background: Atherosclerosis is potentiated by stimulation of Toll-like receptors (TLRs), w...
Low-density lipoprotein cholesterol lowering, most notably via statin therapy, has successfully redu...
Low-density lipoprotein cholesterol lowering, most notably via statin therapy, has successfully redu...
BACKGROUND:Platelets are key components in atherogenesis and determine the course of its clinical se...
Atherosclerosis is the leading cause of cardiovascular disease (CVD). Traditional risk factors can b...
BACKGROUND: Inflammation and matrix degradation are the hallmarks of high-risk atherosclerosis that ...
Atherosclerosis is the underlying cause of coronary artery disease and cerebrovascular disease. Risk...
Objective: Atherosclerosis is associated with increased levels of plasma cytokines and expression of...
Innate immunity is the first line of defence against invading micro-organisms. The family of Toll-li...
Inflammation drives atherosclerosis. Toll-like receptor-2 and -4 are so far the strongest candidates...
Background - The ability to mount a prominent inflammatory response to bacterial pathogens confers a...
Background—Transcriptional profiles are available for a variety of cardiovascular-related diseases. ...
Background: Adaptive immunity has been implicated in atherosclerosis in animal models and small clin...
Atherosclerosis is a multi-factorial inflammatory disease and is the primary initiator of cerebrovas...
Atherosclerosis is a multi-factorial inflammatory disease and is the primary initiator of coronary a...
<p>Background: Atherosclerosis is potentiated by stimulation of Toll-like receptors (TLRs), w...
Low-density lipoprotein cholesterol lowering, most notably via statin therapy, has successfully redu...
Low-density lipoprotein cholesterol lowering, most notably via statin therapy, has successfully redu...
BACKGROUND:Platelets are key components in atherogenesis and determine the course of its clinical se...